Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00189228 · ClinicalTrials.gov registry record · NA
Immune Dysfunction in Allergic Asthma
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00189228: Completed NA study, sponsored by University of New Mexico.
NCT00189228 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00189228, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.
Primary Outcome
Asthma and control patients are immunized with KLH. Mean levels of anti-KLH antibody as described above. This is measured by ELISA and expressed as ELISA units which are derived by dilution of serum samples until the result falls on a linear portion of the response curve. Final values are derived from ELISA units and the serum dilution
Interventions
- DRUG Xolair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00189228 record still lists
NCT00189228 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Xolair is the first listed.
NCT00189228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00189228 about?
NCT00189228 is a clinical study titled "Immune Dysfunction in Allergic Asthma". We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.
What is the current status of trial NCT00189228?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2005-09. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00189228?
The interventions under investigation include: Xolair (DRUG).
Who is sponsoring clinical trial NCT00189228?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00189228's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia